Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II

Karolinska University Hospital

Status: Unknown

Conditions: Atrial Fibrillation; Stroke

Treatments: Other: ECG screening (Zenicor-ECG) for atrial fibrillation

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02743416

STROKESTOP II

Details and patient eligibility

About

STROKESTOP II will study if the biomarker NT-proBNP together with single-lead ECG can be used as a primary population screening tool for silent atrial fibrillation, and builds on previous results from the STROKESTOP study.

Enrollment: 6,868 patients

Sex: All

Ages: 75 to 76 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Individuals born 1940 and 1941 residing in Stockholm at the time of inclusion

Exclusion criteria

• Not fulfilling the inclusion criteria

Trial design

6,868 participants in 2 patient groups

ECG screening

Description:

Will be screened for AF using only one-stop protocol

Treatment:

Other: ECG screening (Zenicor-ECG) for atrial fibrillation

Control group

Description:

as per regular standard as of today